Switch from antagonist to agonist of the androgen receptor blocker bicalutamide is associated with prostate tumour progression in a new model system

por Culig, Z, Hoffmann, J, Erdel, M, Eder, I E, Hobisch, A, Hittmair, A, Bartsch, G, Utermann, G, Schneider, M R, Parczyk, K, Klocker, H
Publicado 1999

Interleukin 1beta mediates the modulatory effects of monocytes on LNCaP human prostate cancer cells.

por Culig, Z., Hobisch, A., Herold, M., Hittmair, A., Thurnher, M., Eder, I. E., Cronauer, M. V., Rieser, C., Ramoner, R., Bartsch, G., Klocker, H., Konwalinka, G.
Publicado 1998